Colombia takes an important step in defining the public interest in compulsory licensing case
(More on Colombia here: /colombia)
Andrea Carolina Reyes Rojas informs us that a committee appointed to consider a request for a compulsory license on the leukemia drug Imatinib has decided that there are public interest reasons to do so.
A copy of the decision is available here. Andrew Goldman shares some thoughts and context here.